Haemorrhage Clinical Trial
Official title:
Comparing Blood Loss Between Manual Separation & Conservative Management for Removal of the Placenta During Caesarean Section; a Randomized Controlled Study
to compare the blood loss during caesarean section between two different methods of separating the placenta after fetal extraction, keeping in mind that most blood loss occurs after placental separation.
We are planning a study of a continuous response variable from independent control and
experimental subjects with 1 control(s) per experimental subject. In a previous study1 the
response within each subject group was normally distributed with standard deviation up to
272. If the true difference in the experimental and control means is 37, we will need to
study 249 experimental subjects and 249 control subjects to be able to reject the null
hypothesis that the population means of the experimental and control groups are equal with
probability (power) 0.8. The Type I error probability associated with this test of this null
hypothesis is 0.5. To allow for 15% drop, the sample on each arm will be increased to 287.
After approval of the ethical & scientific committee of the obstetrics & gynecology
department, Kasr Alainy Hospital, Cairo University. A randomized controlled trial involving
at least 574 patients will be undertaken in which, all patients will be randomized in to two
groups, with a closed envelope system containing equal number allocations for both groups
(1:1 bias) by the operating room nurse. Informed consent will be taken from all patients
before caesarean section.
Group A will contain 287 patients in which manual separation of the placenta will be done
immediately after fetal extraction & cord clamping, where the fingers of the surgeon will be
insinuated between the margin of the placenta and the uterine cavity, then by sawing
movement and controlled traction by the other hand till placenta is separated from the
uterine cavity. Group B will also contain 287 patients but following fetal extraction and
cord clamping, the placenta will be left insitu & uterus is massaged awaiting spontaneous
placental separation.
In both groups a uterotonic agent Oxytocin 5IU( syntocinon® Sandoz Pharmaceuticals
Corporation East Hanover, New Jersey) will be given I.V in 250 ml ringer solution
immediately after cord clamping, and the uterus is exteriorized,& the caesarean is performed
by surgeons of equal training level (Senior residants). Any serious tears or extensions into
the lower uterine segment, along with any major bleeding points on the suture line will be
repaired before attending to the placenta in both groups to prevent any serious blood loss
before placental separation, which will cause the results to be biased & increase the risk
of major hemorrhage for the patient. The blood lost will be measured by recording the fluid
in the suction apparatus before and after placental separation, keeping in mind that most
fluid in the apparatus before fetal extraction was amniotic fluid and therefore will be
deducted from the total. The net amount of fluid in the suction apparatus will be added the
volume of fluid collected from blood soaked sterilized towels used after fetal extraction
and the under buttocks drapes placed under the patient.
The volume of fluid collected in soaked materials will be calculated according to (2) AWHONN
Practice Brief Number 1, where the dry weight of these materials in grams before the
operation is recorded and subtracted from the soaked weight & converted to milliliters. The
net weight will be calculated through the following equation WET Item Gram Weight - DRY Item
Gram Weight = Milliliters of Blood within the item. (2) Descriptive data was recorded along
with blood loss after placental separation, and the time taken for placenta to spontaneously
separate in group B. Preoperative & 6 hour postoperative hemoglobin will be recorded in both
groups. All statistical calculations were done using computer program SPSS (Statistical
Package for the Social Science; SPSS Inc., Chicago, IL, USA) release 15 for Microsoft
Windows (2006). PS Power and Sample size calculations software, version 2.1.30 for MS
windows, was used to calculate sample size (Dupont & Vanderbilt, USA)
References:
1. Gol M, Baloglu A, Aydin C, Ova L, Yensel U, Karci L.(2004): Does manual removal of the
placenta affect operative blood loss during cesarean section? Eur J Obstet Gynecol
Reprod Biol. 2004 Jan 15;112(1):57-60.
2. AWHONN Practice Brief (2014): Quantification of Blood Loss: AWHONN Practice Brief
Number 1. JOGNN, 00, 1-3; 2014. DOI: 10.1111/1552-6909.12519.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02203968 -
Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)
|
Phase 1/Phase 2 | |
Recruiting |
NCT06097637 -
Underwater Endoscopic Mucosal Resection Versus Metal Clips With Hot Snare Polypectomy for Resection of Big Pedunculated Colorectal Polyps:a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT06097650 -
Cold Snare Polypectomy Versus Hot Snare Polypectomy for Resection of Small Pedunculated Colorectal Polyps:a Randomized Controlled Trial
|
N/A | |
Completed |
NCT01938768 -
Effects of an Early Prehospital Administration of Tranexamic Acid on Hyperfibrinolysis in Multiple Trauma
|
N/A | |
Completed |
NCT02765022 -
Clip Closure of Mucosal Defects After Endoscopic Mucosal Resection.
|
N/A | |
Completed |
NCT01629381 -
Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy
|
Phase 2 | |
Terminated |
NCT01961804 -
PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma
|
Phase 3 | |
Completed |
NCT02106000 -
A Non-investigational Product (IP) Study to Investigate Lung Function in Women in the Third Stage of Labour
|
N/A | |
Completed |
NCT02344069 -
Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage
|
Phase 2 | |
Completed |
NCT00440401 -
TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)
|
Phase 4 | |
Completed |
NCT02745041 -
Fibrinogen Early In Severe Trauma studY
|
Phase 2 |